Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
30.51
-0.07 (-0.23%)
May 27, 2025, 3:46 PM - Market open
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.68 billion as of May 27, 2025. Its market cap has increased by 47.58% in one year.
Market Cap
3.68B
Enterprise Value
2.33B
1-Year Change
47.58%
Ranking
Category
Stock Price
$30.51
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.68B, an increase of 265.03%. That is a compound annual growth rate of 29.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 3.69B | 6.24% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.96B |
| Johnson & Johnson | 367.91B |
| AbbVie | 328.04B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 265.34B |
| Abbott Laboratories | 231.85B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |